Results 81 to 90 of about 815 (103)

Efficient <i>in vitro</i> assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains. [PDF]

Antimicrob Agents Chemother
Woodall M, Ellis S, Zhang S, Kembou-Ringert J, Kite K-A, Buggiotti L, Jacobs AI, Agyeman AA, Masonou T, Palor M, McHugh TD, Breuer J, Standing JF, Smith CM.   +13 more
europepmc   +1 more source

Antiviral Activity of Essential Oil from <i>Populus balsamifera</i> L. Buds and Its Major Compounds Against Betacoronavirus HCoV-OC43 Using a Sensitive Cytoprotection Assay. [PDF]

Molecules
Girard L, Côté H, Pichette A, Savard J, Ripoll L, Legault J.   +5 more
europepmc   +1 more source

Clinical evaluation of a direct RT-qPCR method for feline coronavirus detection in effusions using the PicoGene PCR1100 system. [PDF]

J Vet Diagn Invest
Doki T, Yonezawa Y, Katayama M, To K, Takano T.   +4 more
europepmc   +1 more source

Safety of RNA-Dependent RNA Polymerase Inhibitors, Molnupiravir and VV116, for Oral Treatment of COVID-19: A Meta-Analysis. [PDF]

Iran J Med Sci
Zheng Z, Zhou J, Song Y.
europepmc   +1 more source

Preclinical characterization and anti-RSV efficacy of an oral C-nucleoside derivative. [PDF]

Acta Pharm Sin B
Chen Y, Liu Y, Li G, Peng C, Liang D, Yang S, Zheng P, Li S, Guo D, Zhou Q, Zhang X.   +10 more
europepmc   +1 more source

From Challenge to Cure: A Look at Feline Infectious Peritonitis and Emerging Treatment Strategies and Breakthroughs. [PDF]

Vet Sci
Mir S, Peters M, Penny G, Agsaoa A, Mir M.   +4 more
europepmc   +1 more source

3-Deazaguanosine inhibits SARS-CoV-2 viral replication and reduces the risk of COVID-19 pneumonia in hamster. [PDF]

iScience
Saito-Tarashima N, Koma T, Hinotani N, Yoshida K, Ogasa M, Murai A, Inoue S, Kondo T, Doi N, Tsuneyama K, Nomaguchi M, Minakawa N.   +11 more
europepmc   +1 more source

Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase. [PDF]

NAR Mol Med
Sloan A, Gordon CJ, Prévost J, Audet J, Fulton K, Woolner E, Chang MH, Walker SM, Tchesnokov EP, Das K, Safronetz D, Götte M.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A clean industrial scheme for de-ketalization of EIDD-2801 intermediate in water to give molnupiravir (MK-4482) anti-COVID-19 agent (containing its pharmaceutical analytical analysis)

Scientiae Radices, 2023
Due to the need for molnupiravir (EIDD-2801, MK-4482) anti-COVID-19 agent, in the present report, we have systematically investigated the effect of different solvents, acids (as catalyst), temperature, and other parameters which play rolls in De-ketalization process of its key intermediate. At the first glance, it might seem to be easy, but the complex
Seyyed Amir Siadati, Marjan Samadi, Mehdi Soheilizad, Loghman Firoozpour, Meghdad Payab, Saeid Bagherpour, Bahareh Dindari   +6 more
openaire   +1 more source